The aroxysmal supraventricular tachycardia
The aroxysmal supraventricular tachycardia Atrial fibrillation is a common cardiac arrhythmia, but another significant condition that affects the heart’s electrical system is atrioventricular nodal reentrant tachycardia (AVNRT), often referred to as paroxysmal supraventricular tachycardia (PSVT). This arrhythmia is characterized by sudden episodes of rapid heart rate originating above the ventricles, primarily due to abnormal electrical pathways within or near the atrioventricular (AV) node. Although it can be alarming for patients, AVNRT is generally considered benign and manageable with proper diagnosis and treatment.
AVNRT occurs when there is a reentrant circuit within the AV node, which leads to rapid stimulation of the atria and ventricles. The reentrant pathway usually involves two limbs: a fast pathway and a slow pathway. During an episode, electrical impulses can loop through these pathways, causing the heart to beat much faster than normal—often reaching rates of 150 to 250 beats per minute. Patients experiencing AVNRT may notice sudden onset and termination of palpitations, accompanied by symptoms such as dizziness, shortness of breath, chest tightness, or even fainting in severe cases.
The exact cause of AVNRT is not entirely understood, but certain factors can predispose individuals to episodes. These include structural heart abnormalities, genetic predisposition, or increased vagal tone. Sometimes, episodes are triggered by stress, caffeine, alcohol, or stimulants. The episodes can occur sporadically or be recurrent, impacting a person’s quality of life depending on frequency and severity. The aroxysmal supraventricular tachycardia
The aroxysmal supraventricular tachycardia Diagnosis of AVNRT typically involves an electrocardiogram (ECG), which captures the rapid heart rhythm during an episode. The ECG often shows a narrow QRS complex tachycardia with a regular rhythm. In some cases, additional electrophysiological studies are conducted to map the electrical pathways within the heart, especially if the diagnosis is unclear or if the episodes are frequent and severe. These studies help tailor treatment options and assess the risk of other arrhythmias.
Management of AVNRT includes acute and long-term treatments. During an episodes, vagal maneuvers such as the Valsalva maneuver or carotid sinus massage can sometimes terminate the arrhythmia by stimulating the vagus nerve and slowing conduction through the AV node. If these are ineffective, medications like adenosine are administered intravenously; adenosine has a rapid onset and effectively restores normal rhythm.
The aroxysmal supraventricular tachycardia For recurrent or persistent AVNRT, catheter ablation is considered the definitive treatment. This minimally invasive procedure involves threading a catheter into the heart to destroy the abnormal electrical pathways responsible for the reentrant circuit. Success rates are high, and many patients experience complete resolution of episodes after ablation.
While AVNRT is usually benign, it can pose risks if episodes are frequent or if the heart rate becomes excessively fast, leading to decreased cardiac output. Patients with AVNRT should work closely with their healthcare providers to develop a management plan and to monitor for any potential complications. Lifestyle modifications, such as avoiding known triggers and managing stress, can help reduce the frequency of episodes. Regular follow-up is essential for ensuring optimal heart health. The aroxysmal supraventricular tachycardia
The aroxysmal supraventricular tachycardia In summary, AVNRT is a common and treatable form of supraventricular tachycardia characterized by episodes of rapid heart rate caused by reentry within the AV node. With appropriate diagnosis and treatment options like vagal maneuvers, medications, or catheter ablation, most patients can lead normal, symptom-free lives.
